FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Mar 26, 2026
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on March 26, 2026, issued by the Florida District Office, covering biologics.
View Company Profile
ID · 5a8084e9-9266-4959-a96d-357e42fcf701
Inspection Facts
- Inspection number
- 1309376
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 2, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 26, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1121342 - 2020-02-06
- FDA Inspection 1035764 - 2017-11-14
- FDA Inspection 987798 - 2016-08-02
- FDA Inspection 893894 - 2014-08-26
- FDA Inspection 807212 - 2012-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.